Cannabis News Box

Big Pharma, Big Tobacco betting big on legal weed

Big Pharma, Big Tobacco betting big on legal weed

Bethan Rose Jenkins, Cannabis News Writer/Editorial

February 28, 2019

Major pharmaceutical drug companies are getting involved in legal cannabis, albeit a bit discreetly. According to recent reports, patents are being snapped up left, right and center, while some pharmaceutical giants are dishing out all their dollar on research and development (R&D). So long as a drug is deemed...

Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD

Cannabis study: Whole-plant cannabis is more powerful at treating epilepsy than CBD

Bethan Rose Jenkins, Cannabis News Writer/Editorial

October 5, 2018

The number of cannabis studies demonstrating the plant’s medical potency for the treatment of epilepsy, among many other ailments, is rapidly increasing.  In June, the Food and Drug Administration (FDA) approved a cannabis-based medicine for epileptic patients, known as Epidiolex. The drug, which w...

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Will Epidiolex be the first cannabis-based drug to be approved as an epilepsy treatment?

Bethan Rose Jenkins, Cannabis News Writer/Editorial

May 3, 2018

A cannabis-based medication for epilepsy could be the first to gain approval by the Food and Drug Administration (FDA). Created by British company GW Pharmaceuticals, cannabis-based epilepsy treatment Epidiolex will undergo FDA review this June. Things are looking hopeful, with a panel of 13 advisors...

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

FDA gives positive review for GW Pharmaceuticals’ cannabis-based medicine Epidiolex

Bethan Rose Jenkins, Cannabis News Writer/Editorial

April 19, 2018

Epidiolex, a cannabis-based treatment for epilepsy from GW Pharmaceuticals, received a positive review from staff at the Federal Drug Administration (FDA) on Tuesday. GW Pharmaceuticals provided “substantial evidence” to prove the drug’s suitability for treating two rare types of epilepsy. ...

epidiolex